DB
DGX icon

Danske Bank’s Quest Diagnostics DGX Stock Holding History

Danske Bank’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Sell
68,561
-1,400
-2% -$275K 0.03% 382
2026
Q1 		$13.7M Sell
69,961
-5,200
-7% -$1.01M 0.03% 378
2025
Q4 		$13M Buy
75,161
+11,200
+18% +$2.04M 0.03% 388
2025
Q3 		$12.2M Buy
63,961
+900
+1% +$160K 0.03% 385
2025
Q2 		$11.3M Buy
63,061
+4,102
+7% +$712K 0.03% 412
2025
Q1 		$9.98M Buy
58,959
+7,500
+15% +$1.23M 0.03% 407
2024
Q4 		$7.76M Sell
51,459
-6,202
-11% -$965K 0.02% 454
2024
Q3 		$8.95M Sell
57,661
-100
-0.2% -$14.9K 0.03% 416
2024
Q2 		$7.91M Sell
57,761
-8,064
-12% -$1.1M 0.03% 422
2024
Q1 		$8.76M Buy
+65,825
New +$8.54M 0.03% 443

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Danske Bank's DGX Position: Q2 2026 in Review

Danske Bank reduced its Quest Diagnostics (DGX) stake by 2% in Q2 2026, selling an estimated $275K and leaving 68,561 shares worth $14.5M. The position accounts for 0.03% of the portfolio, ranked #382.

Danske Bank first reported a position in DGX in Q1 2024 and has held it in 10 quarters since. 976 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Danske Bank held 68,561 shares of Quest Diagnostics worth $14.5M as of Q2 2026.
  • Danske Bank sold 1,400 Quest Diagnostics shares in Q2 2026, an estimated $275K.
  • Quest Diagnostics made up 0.03% of Danske Bank's portfolio in Q2 2026, its #382 holding.
  • Danske Bank first reported a position in Quest Diagnostics in Q1 2024 and has held it in 10 quarters since.
  • 976 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.